ImmunoCellular Therapeutics
Immunocellular Therapeutics’ work in industry-leading, next-generation cancer vaccine immunotherapies.
Launch date
Employees
Market cap
CAD21.3m
Enterprise valuation
CAD21m (Public information from Sep 2024)
Share price
$0.079 IMUC
Calabasas California (HQ)
Authorizing premium user...